泰凌医药：协助查实合同不影响日常业务 股票复牌

Core Viewpoint - 泰凌医药 has received a request from the Hong Kong government to assist in verifying a contract related to an independent third party, which does not impact its daily operations [1] Company Operations - The company stated that the matter does not affect its daily business activities [1] - As of the announcement date, the company's directors and senior management have no legal liabilities [1] Stock Trading - The company's stock was suspended from trading at 1 PM on August 19, 2025, at its request [1] - Trading is planned to resume at 9 AM on August 20, 2025 [1]